Status:
RECRUITING
D2 vs D3 Lymph Node Dissection for Left Colon Cancer
Lead Sponsor:
Russian Society of Colorectal Surgeons
Collaborating Sponsors:
I.M. Sechenov First Moscow State Medical University
G.V. Bondar Republican Cancer Center
Conditions:
Colon Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissec...
Detailed Description
Discussion about optimal type of lymph node dissection in colorectal cancer continues during last 15 years, when in Europe was presented concept of complete mesocolic excision. However, this concepts ...
Eligibility Criteria
Inclusion
- Agreement of the patient to participate in trial
- Colon cancer (only adenocarcinoma )
- The tumor located between the splenic flexure and rectosigmoid junction
- cT3-Т4а,b
- cN0-2
- cM0
- Tolerance of chemotherapy
- ASA 1-3
Exclusion
- сТis - Т2, сТ4b (tail of the pancreas, stomach, small bowel, ureter, urinary bladder)
- Preoperative complications of the tumor (perforation and full bowel 3. obstruction)
- Previous radiotherapy or chemotherapy
- Synchronous or metachronous tumors
- Women during Pregnancy or breast feeding period
Key Trial Info
Start Date :
March 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2033
Estimated Enrollment :
1381 Patients enrolled
Trial Details
Trial ID
NCT04364373
Start Date
March 31 2020
End Date
December 31 2033
Last Update
April 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic of coloproctology and minimally invasive surgery
Moscow, Russia, 119435